← Insider buys

Ronald T Hundzinski has bought stock on 3 days since Aug 2018

Director at InfuSystem Holdings, Inc., and 2 other companies

SEC CIK 0001488024 · Filings on SEC.gov ↗

$233KBought
$1.0MSold
May 20Last buy

Ronald T Hundzinski's record

3 months after each buy, from the first price a copier could get.

2 buys have 3 months of prices so far. A record shows here at 3.

Companies

Every filing

6 filings since Mar 2016, newest first

About Ronald T Hundzinski

Ronald T. Hundzinski is a corporate finance executive and board director who currently serves as an independent Director of InfuSystem Holdings, Inc., having joined the company’s Board of Directors on November 12, 2024.( In this role, he contributes governance and financial oversight to the national health care service provider and has reported equity-based compensation transactions in InfuSystem common stock as a corporate insider under SEC Form 4 filings.( He also serves as Non-Executive Chairman of the Board at Gentherm, Inc., where he has been a director since 2016, and Chairman since 2017–2020, overseeing a thermal management and comfort technologies business in the automotive and medical industries.(

Hundzinski retired in 2023 after a distinguished career as Chief Financial Officer and senior finance leader at several public companies.( He was CFO and an Executive Director of TI Fluid Systems from January 2020 until his retirement in April 2023, previously serving as Executive Vice President of Finance at Tenneco Inc. from 2018 to 2019 and Executive Vice President and Chief Financial Officer of BorgWarner Inc. from 2012 to 2018.( Earlier at BorgWarner, he held multiple finance leadership positions including Treasurer, Principal Accounting Officer, Vice President and Controller, and Vice President of Finance for the Turbo Systems business.( Hundzinski holds a Bachelor of Business Administration in Finance from Western Michigan University and a Master of Business Administration from the University of Colorado (University of Colorado Denver).(

Written by Perplexity from public sources.

Filings come from SEC EDGAR. Not investment advice.